Next Article in Journal
A Statistical Analysis of the Robustness of Alternate Genetic Coding Tables
Next Article in Special Issue
Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
Previous Article in Journal / Special Issue
A Single-Molecule Study on the Structural Damage of Ultraviolet Radiated DNA
Open AccessReview

CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics

Department of Thoracic, Cardiac and Vascular surgery, University Hospital Tuebingen, Tuebingen, Germany, Calwerstr.7/1, D72076 Tuebingen, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2008, 9(4), 668-678; https://doi.org/10.3390/ijms9040668
Received: 18 December 2007 / Revised: 3 April 2008 / Accepted: 24 April 2008 / Published: 24 April 2008
(This article belongs to the Special Issue Nucleic Acid Derivatives in Emerging Technologies)
Aptamers, single stranded DNA or RNA molecules, generated by a method called SELEX (systematic evolution of ligands by exponential enrichment) have been widely used in various biomedical applications. The newly developed Cell-SELEX (cell based-SELEX) targeting whole living cells has raised great expectations for cancer biology, -therapy and regenerative medicine. Combining nanobiotechnology with aptamers, this technology opens the way to more sophisticated applications in molecular diagnosis. This paper gives a review of recent developments in SELEX technologies and new applications of aptamers. View Full-Text
Keywords: cell-SELEX; aptamer; nanotechnology cell-SELEX; aptamer; nanotechnology
Show Figures

MDPI and ACS Style

Guo, K.-T.; Ziemer, G.; Paul, A.; Wendel, H.P. CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics. Int. J. Mol. Sci. 2008, 9, 668-678.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop